|
π¦
|
Blockade of XBP1 splicing by inhibition of IRE1Ξ± is a promising therapeutic option in multiple myeloma.
25 auth.
N. Mimura,
M. Fulciniti,
G. Gorgun,
Y. Tai,
D. Cirstea,
L. Santo,
Yiguo Hu,
C. Fabre,
J. Minami,
H. Ohguchi,
T. Kiziltepe,
H. Ikeda,
Y. Kawano,
Maureen French,
M. Blumenthal,
...
Victor L Tam,
N. Kertesz,
U. Malyankar,
M. Hokenson,
T. Pham,
Qingping Zeng,
J. Patterson,
P. Richardson,
N. Munshi,
K. Anderson
|
8 |
2011 |
8
π¦
|
|
π
|
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.
17 auth.
G. GΓΆrgΓΌn,
E. Calabrese,
E. Soydan,
T. Hideshima,
G. Perrone,
Madhavi Bandi,
D. Cirstea,
L. Santo,
Yiguo Hu,
Y. Tai,
...
Sabikun Nahar,
N. Mimura,
C. Fabre,
N. Raje,
N. Munshi,
P. Richardson,
K. Anderson
|
7 |
2009 |
7
π
|
|
π
|
Dilated Cardiomyopathy Caused by Aberrant Endoplasmic Reticulum Quality Control in Mutant KDEL Receptor Transgenic Mice
11 auth.
H. Hamada,
Masashi Suzuki,
S. Yuasa,
N. Mimura,
N. Shinozuka,
Yuki Takada,
...
Misao Suzuki,
T. Nishino,
H. Nakaya,
H. Koseki,
T. Aoe
|
7 |
2004 |
7
π
|
|
π
|
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
16 auth.
J. Minami,
R. Suzuki,
Ralph Mazitschek,
G. Gorgun,
B. Ghosh,
D. Cirstea,
Y. Hu,
N. Mimura,
H. Ohguchi,
F. Cottini,
...
J. Jakubikova,
N. Munshi,
S. Haggarty,
P. Richardson,
T. Hideshima,
K. Anderson
|
7 |
2014 |
7
π
|
|
π
|
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
21 auth.
T. Hideshima,
J. Qi,
Ronald M. Paranal,
Weiping Tang,
E. Greenberg,
N. West,
M. Colling,
G. Estiu,
Ralph Mazitschek,
J. Perry,
...
H. Ohguchi,
F. Cottini,
N. Mimura,
G. GΓΆrgΓΌn,
Y. Tai,
P. Richardson,
Ruben D Carrasco,
O. Wiest,
S. Schreiber,
K. Anderson,
J. Bradner
|
6 |
2016 |
6
π
|
|
π¦
|
Novel therapeutic strategies for multiple myeloma.
N. Mimura,
T. Hideshima,
K. Anderson
|
6 |
2015 |
6
π¦
|
|
π
|
The KDM3AβKLF2βIRF4 axis maintains myeloma cell survival
18 auth.
H. Ohguchi,
T. Hideshima,
M. Bhasin,
G. Gorgun,
L. Santo,
M. Cea,
M. Samur,
N. Mimura,
R. Suzuki,
Y. Tai,
...
Ruben D Carrasco,
N. Raje,
P. Richardson,
N. Munshi,
H. Harigae,
T. Sanda,
J. Sakai,
K. Anderson
|
6 |
2015 |
6
π
|
|
π
|
Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
7 auth.
J. Bae,
Robert W Smith,
J. Daley,
N. Mimura,
Y. Tai,
K. Anderson,
...
N. Munshi
|
6 |
2012 |
6
π
|
|
π
|
Dual Inhibition of Canonical and Noncanonical NF-ΞΊB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma
16 auth.
C. Fabre,
N. Mimura,
K. Bobb,
S. Kong,
G. Gorgun,
D. Cirstea,
Yiguo Hu,
J. Minami,
H. Ohguchi,
Jie Zhang,
...
J. Meshulam,
Ruben D Carrasco,
Y. Tai,
P. Richardson,
T. Hideshima,
K. Anderson
|
6 |
2012 |
6
π
|
|
π¦
|
Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.
18 auth.
N. Mimura,
T. Hideshima,
T. Shimomura,
R. Suzuki,
H. Ohguchi,
Ola Rizq,
S. Kikuchi,
Y. Yoshida,
F. Cottini,
J. Jakubikova,
...
D. Cirstea,
G. Gorgun,
J. Minami,
Y. Tai,
P. Richardson,
T. Utsugi,
A. Iwama,
K. Anderson
|
6 |
2014 |
6
π¦
|
